Granite Point Mortgage Trust amends JPMorgan repurchase deal
Granite Point Mortgage Trust has amended its repurchase agreement with JPMorgan, increasing the facility amount to $727 million, impacting the REIT sector.
Pagaya Technologies reveals borrower data insights in filing
Pagaya Technologies Ltd. shares insights on borrower characteristics, impacting its strategy and the finance services sector.
Blackstone Real Estate Income Trust Sells $21.6M in Shares
Blackstone Real Estate Income Trust, Inc. reported a $21.6 million sale of unregistered shares as part of its continuous private offering to accredited investors.
Federal Home Loan Bank of New York Updates Financial Obligations
Federal Home Loan Bank of New York updates its financial obligations, indicating a strategic shift in funding amidst changing market conditions.
Capital One Multi-Asset Execution Trust to Issue Class A Notes
Capital One Multi-Asset Execution Trust announces the issuance of new Class A Notes, reflecting ongoing activity in the asset-backed securities market.
Venrock Healthcare Capital Partners XP Reports Major Stake in Lycia
Venrock Healthcare Capital Partners XP, L.P. reveals significant ownership in Lycia Therapeutics, signaling a strategic investment in the biological products sector.
Eli Lilly Takes Major Stake in Lycia Therapeutics
Eli Lilly & Co. acquires a significant stake in Lycia Therapeutics, signaling a strategic partnership in the biological products sector.
Versant Vantage II GP Reports Ownership Changes in Lycia
Versant Vantage II GP, L.P. updates on its ownership stakes in Lycia Therapeutics, signaling strategic interests in the biotech sector.
Touami Sofia exercises stock options at Lycia Therapeutics
Touami Sofia, Chief Business Officer at Lycia Therapeutics, exercises stock options for 68,755 shares, signaling confidence in the company's future.
Lycia Therapeutics CEO Reports Major Stock Option Transaction
Lycia Therapeutics' CEO Aetna Wun Trombley reports a significant stock option transaction, signaling a strategic move for the company in the biological products industry.
Lycia Therapeutics director reports major stock option transactions
Lycia Therapeutics' director William J.L. Rieflin reports significant stock option transactions, signaling confidence in the company's future.
Lycia Therapeutics grants stock options to director Henderson
Lycia Therapeutics has granted stock options to director Jane Henderson, emphasizing its commitment to talent retention in the biological products sector.
Lycia Therapeutics director reports stock option transactions
Lycia Therapeutics, Inc. discloses stock option transactions by director Fischer Laurent, emphasizing executive retention strategies in the biological products sector.
Vroom, Inc. Reports Convertible Notes Transactions
Vroom, Inc. discloses significant transactions involving convertible notes, impacting its financial strategy and the retail-auto industry.
Keller Eric L. Receives Stock Option Grant as CEO of Retension
Keller Eric L. has been granted a stock option as CEO of Retension Pharmaceuticals, enhancing leadership stability and growth potential in the industry.
Greenbrier Holdings reports share issuance from note repurchase
Greenbrier Holdings details significant transactions involving Westrock Coffee, including share issuance and convertible note repurchase, signaling strategic financial moves.
HF Direct Investments Pool amends convertible notes with Westrock
HF Direct Investments Pool, LLC has amended its convertible notes with Westrock Coffee Co, changing terms like interest rate and maturity date.
Westrock Coffee Co Amends Convertible Notes Terms
Westrock Coffee Co has amended its convertible notes, impacting its financial strategy and signaling industry shifts in the beverage sector.
Westrock Coffee Co repurchases convertible notes, issues stock
Westrock Coffee Co repurchased convertible notes, issuing over 297,000 shares of common stock, reflecting strategic capital management in the beverage industry.
Herzfeld reports tender offer share transaction for fund
Erik Mervin Herzfeld reports a transaction involving nearly 5,000 shares of Herzfeld Credit Income Fund, reflecting ongoing activity in the investment fund sector.